Outcomes of Therapeutic Strategies in Merkel Cell Carcinoma (MCC) Among Patients Aged 0-30.

Background: Merkel cell carcinoma (MCC) in patients under 30 years is exceptionally rare, representing less than 1% of all cases. Limited data exist regarding optimal therapeutic approaches and outcomes in this age group.

Objective: To analyze clinicopathologic patterns and therapeutic outcomes of MCC in patients aged 0-30 years through systematic review of published literature.